Small-molecule Akt-activation in airway cells induces NO production and reduces IL-8 transcription through Nrf-2

Respir Res. 2021 Oct 19;22(1):267. doi: 10.1186/s12931-021-01865-y.

Abstract

Background: The non-cancerous functions of Akt in the airway are understudied. In some tissues, Akt phosphorylates and activates endothelial nitric oxide synthase (eNOS) to produce nitric oxide (NO) that has anti-inflammatory effects. NO production has antibacterial and antiviral effects in the airway, and increasing NO may be a useful anti-pathogen strategy. Akt also stimulates the nuclear factor erythroid 2-related factor 2 (Nrf-2) transcription factor, which transcribes antioxidant genes. Therefore, we hypothesized that activation of the Akt/eNOS pathway, which also activates Nrf-2, may have protective effects in human airway cells against injury.

Methods: To directly test the effects of Akt signaling in the airway, we treated A549 and 16HBE cells as well as primary bronchial, nasal, and type II alveolar epithelial cells with small molecule Akt activator SC79. We examined the effects of SC79 on eNOS activation, NO production, Nrf-2 target levels, and interleukin-8 (IL-8) transcription during exposure to TNF-α or Pseudomonas flagellin (TLR5 agonist). Additionally, air-liquid interface bronchial cultures were treated with cadmium, an oxidative stressor that causes airway barrier breakdown.

Results: SC79 induced a ~ twofold induction of p-eNOS and Nrf-2 protein levels blocked by PI3K inhibitor LY294002. Live cell imaging revealed SC79 increased acute NO production. Quantitative RT-PCR showed a ~ twofold increase in Nrf-2 target gene transcription. TNF-α or flagellin-induced IL-8 levels were also significantly reduced with SC79 treatment. Moreover, the transepithelial electrical resistance decrease observed with cadmium was ameliorated by SC79, likely by an acute increase in tight junction protein ZO-1 levels.

Conclusions: Together, the data presented here demonstrate SC79 activation of Akt induces potentially anti-pathogenic NO production, antioxidant gene transcription, reduces IL-8 transcription, and may protect against oxidative barrier dysfunction in a wide range of airway epithelial cells.

Keywords: Antioxidants; Innate immunity; Lung; Oxidative stress; Pseudomonas aeruginosa; Toll-like receptor.

MeSH terms

  • A549 Cells
  • Acetates / pharmacology*
  • Anti-Inflammatory Agents / pharmacology*
  • Benzopyrans / pharmacology*
  • Electric Impedance
  • Enzyme Activation
  • Enzyme Activators / pharmacology*
  • Epithelial Cells / drug effects*
  • Epithelial Cells / enzymology
  • Epithelial Cells / immunology
  • Humans
  • Interleukin-8 / genetics
  • Interleukin-8 / metabolism*
  • Lung / drug effects*
  • Lung / enzymology
  • Lung / immunology
  • NF-E2-Related Factor 2 / genetics
  • NF-E2-Related Factor 2 / metabolism*
  • Nitric Oxide / metabolism*
  • Nitric Oxide Synthase Type III / metabolism
  • Phosphorylation
  • Pneumonia / enzymology
  • Pneumonia / genetics
  • Pneumonia / immunology
  • Pneumonia / prevention & control*
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Signal Transduction
  • Transcription, Genetic
  • Zonula Occludens-1 Protein / metabolism

Substances

  • 2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester
  • Acetates
  • Anti-Inflammatory Agents
  • Benzopyrans
  • CXCL8 protein, human
  • Enzyme Activators
  • Interleukin-8
  • NF-E2-Related Factor 2
  • NFE2L2 protein, human
  • TJP1 protein, human
  • Zonula Occludens-1 Protein
  • Nitric Oxide
  • NOS3 protein, human
  • Nitric Oxide Synthase Type III
  • Proto-Oncogene Proteins c-akt